000			03648nam a22003855i 4500
001			100364
003			DE-He213
005			20230221040152.0
007			cr nn 008mamaa
008			180130s2018 si | s |||| 0|eng d
020			_a9789811075964 _9
024	7		_a10.1007/978-981-10-7596-4 _2doi
040			_aES-MaUEC _bspa
050		4	_aRC280.L8 2018 EB
245	1	0	_aEarly-Stage Lung Cancer : _bScreening and Management _cedited by Xiangpeng Zheng, Ming Li, Guozhen Zhang.
264		1	_aSingapore _bSpringer International Publishing _c2018
300			_a1 recurso en línea (XXIV, 423 páginas 181 ilustraciones a color)
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
505	0		_aThe pathological advances of early lung adenocarcinoma -- Advancement in Cross-sectional Anatomy of the Lung -- Low-dose CT Screening of Lung Cancer -- The Advances of PET/CT clinical application in micronodular lung cancer -- Angiogenesis-dependent tumor progression -- Pure Ground-glass Nodules -- Part-solid Ground-glass Nodules -- Solid Pulmonary Nodules -- CT-based Categorization of Small Pulmonary Adenocarcinoma and Differential Diagnosis -- Multiple Primary Lung Cancer -- Management Strategies of Micronodular Lung Cancer: Surgical Perspectives -- Management Strategies of Early-stageLung Cancer: Stereotactic Ablative Radiation Therapy -- Radiofrequency ablation -- Case Discussion.
520	3		_aThis book discusses major issues and advances in the diagnosis and treatment of incidentally detected early-stage lung cancer (ESLC). In Part I, pathology and radiology experts comprehensively review the state-of-the-art advances in individual research fields, and offer an update on the cross-sectional anatomy of the lung and post-processing techniques for CT imaging. Part II focuses on the imaging features, differential diagnosis and radiologic-pathologic correlations of ESLCs in the categories pGGN, mGGN and solid nodules in compliance with the Guidelines on Lung Cancer Screening from the National Comprehensive Cancer Network (NCCN). Part III briefly introduces therapeutic management strategies for ESLCs, including surgical and non-surgical approaches, for instance stereotactic ablative radiation therapy (SABR) and radiofrequency ablation (RFA). Lastly, the authors have meticulously prepared 50 clinical cases of pathologically proven benign and malignant pulmonary nodules with in-depth discussion and experts' comments to further readers' understanding of practical imaging and management strategies of ESLCs.
650		7	_aPulmones _xCáncer _2embne _9168954
700	1		_aZheng, Xiangpeng _eeditor literario _0http://id.loc.gov/authorities/names/nr93010009 _0http://viaf.org/viaf/24470371
700	1		_aLi, Ming _eeditor literario _0http://id.loc.gov/authorities/names/n83050964 _0http://viaf.org/viaf/105708073 _941616
700	1		_aZhang, Guozhen _eeditor literario _0http://id.loc.gov/authorities/names/n2009048695 _0http://viaf.org/viaf/96720907
710	2		_aSpringerLink (Online service) _0http://id.loc.gov/authorities/names/no2005046756 _0http://viaf.org/viaf/148105729 _9106996
776	0	8	_iEdición impresa: _z9789811075957
776	0	8	_iEdición impresa: _z9789811075971
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-10-7596-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
490	0		_aMedicine (Springer-11650)
988			_aSpringer_Medicine_2018
998			_b01/2019 _dz _ef _feng _ggw _h0
999			_c100364 _d100364 _x1